Associated Papers
Mutations leading to constitutive active gp130/JAK1/STAT3 pathway.
Pilati C et al.
Cytokine & Growth Factor Reviews, 2015
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
Schwarz LJ et al.
The Journal of Clinical Investigation, 2014
Pathway-driven discovery of rare mutational impact on cancer.
Ahn T et al.
Biomed Research International, 2014
Select a paper to view details